BACKGROUND: Childhood asthma is often characterized by recurrent wheezing, airway hyper-reactivity, atopy, and altered immune characteristics; however, our understanding of the development of these relationships from early in life remains unclear. The aim of our study was to evaluate whether atopy, cytokine production by peripheral blood mononuclear cells (PBMCs), and airway responsiveness, assessed in infants and toddlers, are associated with asthma and airway responsiveness at 4-years of age. METHODS: Infants with eczema (N = 116), enrolled prior to wheezing, were assessed at entry (mean age of 10.7 months), at 1-year follow-up (N = 112), and at 4-years of age (N = 94). Total serum IgE, specific IgE to allergens, and cytokines produced by stimulated PBMCs, were assessed at entry and 1-year follow-up. Spirometry was obtained at all 3-visits, while airway reactivity to methacholine was assessed at entry and 1-year follow-up, and bronchodilator (BD) responsiveness, as well as current asthma was assessed at 4-years of age. RESULTS: We found that pre-school children with asthma had lower spirometry and a greater BD-response. Serum IgE, particularly to egg and/or milk, and altered cytokine production by PBMCs at entry to the study were associated with asthma, lower spirometry, and greater airway responsiveness at 4-years of age. In addition, we found that airway responsiveness, as well as spirometry, tracked from infancy to 4-years of age. CONCLUSIONS: While spirometry and airway responsiveness track longitudinally from early in life, atopy and cytokine production by PBMCs are associated not only with an increased risk of pre-school asthma, but also lower spirometry and increased airway responsiveness.
BACKGROUND: Childhood asthma is often characterized by recurrent wheezing, airway hyper-reactivity, atopy, and altered immune characteristics; however, our understanding of the development of these relationships from early in life remains unclear. The aim of our study was to evaluate whether atopy, cytokine production by peripheral blood mononuclear cells (PBMCs), and airway responsiveness, assessed in infants and toddlers, are associated with asthma and airway responsiveness at 4-years of age. METHODS:Infants with eczema (N = 116), enrolled prior to wheezing, were assessed at entry (mean age of 10.7 months), at 1-year follow-up (N = 112), and at 4-years of age (N = 94). Total serum IgE, specific IgE to allergens, and cytokines produced by stimulated PBMCs, were assessed at entry and 1-year follow-up. Spirometry was obtained at all 3-visits, while airway reactivity to methacholine was assessed at entry and 1-year follow-up, and bronchodilator (BD) responsiveness, as well as current asthma was assessed at 4-years of age. RESULTS: We found that pre-school children with asthma had lower spirometry and a greater BD-response. Serum IgE, particularly to egg and/or milk, and altered cytokine production by PBMCs at entry to the study were associated with asthma, lower spirometry, and greater airway responsiveness at 4-years of age. In addition, we found that airway responsiveness, as well as spirometry, tracked from infancy to 4-years of age. CONCLUSIONS: While spirometry and airway responsiveness track longitudinally from early in life, atopy and cytokine production by PBMCs are associated not only with an increased risk of pre-school asthma, but also lower spirometry and increased airway responsiveness.
Authors: H Eigen; H Bieler; D Grant; K Christoph; D Terrill; D K Heilman; W T Ambrosius; R S Tepper Journal: Am J Respir Crit Care Med Date: 2001-03 Impact factor: 21.405
Authors: M Jones; R Castile; S Davis; J Kisling; D Filbrun; R Flucke; A Goldstein; C Emsley; W Ambrosius; R S Tepper Journal: Am J Respir Crit Care Med Date: 2000-02 Impact factor: 21.405
Authors: Marcus H Jones; John Howard; Stephanie Davis; Jeff Kisling; Robert S Tepper Journal: Am J Respir Crit Care Med Date: 2003-02-13 Impact factor: 21.405
Authors: Janet Rothers; Marilyn Halonen; Debra A Stern; I Carla Lohman; Sara Mobley; Amber Spangenberg; Dayna Anderson; Anne L Wright Journal: J Allergy Clin Immunol Date: 2011-06-16 Impact factor: 10.793
Authors: Sarath C Ranganathan; Andrew Bush; Carol Dezateux; Siobhan B Carr; Ah-Fong Hoo; Sooky Lum; Su Madge; John Price; John Stroobant; Angie Wade; Colin Wallis; Hilary Wyatt; Janet Stocks Journal: Am J Respir Crit Care Med Date: 2002-11-15 Impact factor: 21.405
Authors: William A Neaville; Christopher Tisler; Abhik Bhattacharya; Kelly Anklam; Stephanie Gilbertson-White; Rebekah Hamilton; Kiva Adler; Douglas F Dasilva; Kathy A Roberg; Kirstin T Carlson-Dakes; Elizabeth Anderson; Debbie Yoshihara; Ronald Gangnon; Lance D Mikus; Louis A Rosenthal; James E Gern; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2003-10 Impact factor: 10.793
Authors: Daniel Chang; Weiguo Yao; Christina J Tiller; Jeffrey Kisling; James E Slaven; Zhangsheng Yu; Mark H Kaplan; Robert S Tepper Journal: Eur Respir J Date: 2014-09-26 Impact factor: 16.671
Authors: Sarah M Engle; Ching-Yun Chang; Benjamin J Ulrich; Allyson Satterwhite; Tristan Hayes; Kim Robling; Sean E Sissons; Jochen Schmitz; Robert S Tepper; Mark H Kaplan; Jonathan T Sims Journal: Clin Exp Immunol Date: 2022-05-12 Impact factor: 4.330
Authors: Yongyao Fu; Jocelyn Wang; Baohua Zhou; Abigail Pajulas; Hongyu Gao; Baskar Ramdas; Byunghee Koh; Benjamin J Ulrich; Shuangshuang Yang; Reuben Kapur; Jean-Christophe Renauld; Sophie Paczesny; Yunlong Liu; Robert M Tighe; Paula Licona-Limón; Richard A Flavell; Shogo Takatsuka; Daisuke Kitamura; Robert S Tepper; Jie Sun; Mark H Kaplan Journal: Sci Immunol Date: 2022-02-18
Authors: Cindy T McEvoy; Lyndsey E Shorey-Kendrick; Kristin Milner; Diane Schilling; Christina Tiller; Brittany Vuylsteke; Ashley Scherman; Keith Jackson; David M Haas; Julia Harris; Byung S Park; Annette Vu; Dale F Kraemer; David Gonzales; Carol Bunten; Eliot R Spindel; Cynthia D Morris; Robert S Tepper Journal: Eur Respir J Date: 2020-07-02 Impact factor: 16.671
Authors: Sarah M Engle; Ching-Yun Chang; Benjamin J Ulrich; Allyson Satterwhite; Tristan Hayes; Kim Robling; Sean E Sissons; Jochen Schmitz; Robert S Tepper; Mark H Kaplan; Jonathan T Sims Journal: Clin Exp Immunol Date: 2021-11-30 Impact factor: 5.732